Taking aim at tumors

Many of the newest weapons in the war on cancer come in the form of personalized therapies that can target specific changes in an individual's tumor. By disrupting molecular processes in tumor cells, these drugs can keep the tumor from growing and spreading. Researchers are now deploying a new tool in their study of an enzyme called tubulin tyrosine ligase, or TTL.

Read the whole article on Science Daily

More from Science Daily